Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Yael L. Maxwell

February 27, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Daily News

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

Todd Neale

July 04, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Daily News

Sex Differences Diminish With Third-Generation TAVR Device

L.A. McKeown

January 05, 2018

News Daily News

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

June 27, 2014

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

Presentation

Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations

Presenter: Brian R. Lindman

June 25, 2014

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

CME

Advertisement

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

As TAVI Turns 20, How Has the Heart Team Evolved?

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Sex Differences Diminish With Third-Generation TAVR Device

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content